Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
J Menis1, C Twelves21Department of Oncology, University Hospital Santa Maria della Misericordia, Udine, Italy; 2Leeds Cancer Research UK Centre, University of Leeds and St James's Institute of Oncology, Leeds, UKAbstract: Although metastatic breast cancer remains essentially incurable, m...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-08-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/eribulin-halaven-a-new-effective-treatment-for-women-with-heavily-pret-a8159 |